APO RESEARCH · REPORT
Aprotinin
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Product & engineering
Understand the product.
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Selected research
Industry Research
Aprotinin Industry Research Report 2026
Market perspective
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Global Aprotinin key players include Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, etc. Global top four manufacturers hold a share over 25%.
India is the largest market, with a share about 20%, followed by China, and North America, both have a share about 35 percent.
Read the full market overview
In terms of product, Aprotinin (From bovine lung) is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Pharmaceuticals, followed by Scientific Research and Experiment.
Report Scope
This report quantifies the global Aprotinin market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aprotinin Market by Company
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Aprotinin Segment by Type
Aprotinin (From bovine lung)
Recombinant Aprotinin
Aprotinin Segment by Application
Pharmaceuticals
Scientific Research and Experiment
Aprotinin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprotinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aprotinin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprotinin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aprotinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aprotinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aprotinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aprotinin (From bovine lung)
- Recombinant Aprotinin
Applications
- Pharmaceuticals
- Scientific Research and Experiment
Companies covered
- Sigma-Aldrich
- BeiJing Geyuantianrun Bio-tech
- Cayman Chemical
- Taj Pharmaceuticals Limited
- Guangdong Techpool Bio-pharma
- Dadeli
- A.S.Joshi&Company
- Enzymeking Biotechnology
- AdooQ BioScience
- ProSpec
- Yaxin Biotechnology
- AMRESCO
- PanReac AppliChem
- Runhao
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aprotinin Market Size (2021-2032)
- 2.2.2 Global Aprotinin Sales (2021-2032)
- 2.2.3 Global Aprotinin Market Average Price (2021-2032)
- 2.3 Aprotinin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aprotinin (From bovine lung)
- 2.3.3 Recombinant Aprotinin
- 2.4 Aprotinin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Scientific Research and Experiment
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aprotinin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aprotinin Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Aprotinin Revenue of Manufacturers (2021-2026)
- 3.4 Global Aprotinin Average Price by Manufacturers (2021-2026)
- 3.5 Global Aprotinin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aprotinin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aprotinin, Product Type & Application
- 3.8 Global Manufacturers of Aprotinin, Established Date
- 3.9 Global Aprotinin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sigma-Aldrich
- 4.1.1 Sigma-Aldrich Company Information
- 4.1.2 Sigma-Aldrich Business Overview
- 4.1.3 Sigma-Aldrich Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sigma-Aldrich Aprotinin Product Portfolio
- 4.1.5 Sigma-Aldrich Recent Developments
- 4.2 BeiJing Geyuantianrun Bio-tech
- 4.2.1 BeiJing Geyuantianrun Bio-tech Company Information
- 4.2.2 BeiJing Geyuantianrun Bio-tech Business Overview
- 4.2.3 BeiJing Geyuantianrun Bio-tech Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BeiJing Geyuantianrun Bio-tech Aprotinin Product Portfolio
- 4.2.5 BeiJing Geyuantianrun Bio-tech Recent Developments
- 4.3 Cayman Chemical
- 4.3.1 Cayman Chemical Company Information
- 4.3.2 Cayman Chemical Business Overview
- 4.3.3 Cayman Chemical Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cayman Chemical Aprotinin Product Portfolio
- 4.3.5 Cayman Chemical Recent Developments
- 4.4 Taj Pharmaceuticals Limited
- 4.4.1 Taj Pharmaceuticals Limited Company Information
- 4.4.2 Taj Pharmaceuticals Limited Business Overview
- 4.4.3 Taj Pharmaceuticals Limited Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Taj Pharmaceuticals Limited Aprotinin Product Portfolio
- 4.4.5 Taj Pharmaceuticals Limited Recent Developments
- 4.5 Guangdong Techpool Bio-pharma
- 4.5.1 Guangdong Techpool Bio-pharma Company Information
- 4.5.2 Guangdong Techpool Bio-pharma Business Overview
- 4.5.3 Guangdong Techpool Bio-pharma Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangdong Techpool Bio-pharma Aprotinin Product Portfolio
- 4.5.5 Guangdong Techpool Bio-pharma Recent Developments
- 4.6 Dadeli
- 4.6.1 Dadeli Company Information
- 4.6.2 Dadeli Business Overview
- 4.6.3 Dadeli Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dadeli Aprotinin Product Portfolio
- 4.6.5 Dadeli Recent Developments
- 4.7 A.S.Joshi&Company
- 4.7.1 A.S.Joshi&Company Company Information
- 4.7.2 A.S.Joshi&Company Business Overview
- 4.7.3 A.S.Joshi&Company Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 A.S.Joshi&Company Aprotinin Product Portfolio
- 4.7.5 A.S.Joshi&Company Recent Developments
- 4.8 Enzymeking Biotechnology
- 4.8.1 Enzymeking Biotechnology Company Information
- 4.8.2 Enzymeking Biotechnology Business Overview
- 4.8.3 Enzymeking Biotechnology Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Enzymeking Biotechnology Aprotinin Product Portfolio
- 4.8.5 Enzymeking Biotechnology Recent Developments
- 4.9 AdooQ BioScience
- 4.9.1 AdooQ BioScience Company Information
- 4.9.2 AdooQ BioScience Business Overview
- 4.9.3 AdooQ BioScience Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AdooQ BioScience Aprotinin Product Portfolio
- 4.9.5 AdooQ BioScience Recent Developments
- 4.10 ProSpec
- 4.10.1 ProSpec Company Information
- 4.10.2 ProSpec Business Overview
- 4.10.3 ProSpec Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 ProSpec Aprotinin Product Portfolio
- 4.10.5 ProSpec Recent Developments
- 4.11 Yaxin Biotechnology
- 4.11.1 Yaxin Biotechnology Company Information
- 4.11.2 Yaxin Biotechnology Business Overview
- 4.11.3 Yaxin Biotechnology Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yaxin Biotechnology Aprotinin Product Portfolio
- 4.11.5 Yaxin Biotechnology Recent Developments
- 4.12 AMRESCO
- 4.12.1 AMRESCO Company Information
- 4.12.2 AMRESCO Business Overview
- 4.12.3 AMRESCO Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 AMRESCO Aprotinin Product Portfolio
- 4.12.5 AMRESCO Recent Developments
- 4.13 PanReac AppliChem
- 4.13.1 PanReac AppliChem Company Information
- 4.13.2 PanReac AppliChem Business Overview
- 4.13.3 PanReac AppliChem Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 PanReac AppliChem Aprotinin Product Portfolio
- 4.13.5 PanReac AppliChem Recent Developments
- 4.14 Runhao
- 4.14.1 Runhao Company Information
- 4.14.2 Runhao Business Overview
- 4.14.3 Runhao Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Runhao Aprotinin Product Portfolio
- 4.14.5 Runhao Recent Developments
5 Global Aprotinin Market Scenario by Region
- 5.1 Global Aprotinin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aprotinin Sales by Region: 2021-2032
- 5.2.1 Global Aprotinin Sales by Region: 2021-2026
- 5.2.2 Global Aprotinin Sales by Region: 2027-2032
- 5.3 Global Aprotinin Revenue by Region: 2021-2032
- 5.3.1 Global Aprotinin Revenue by Region: 2021-2026
- 5.3.2 Global Aprotinin Revenue by Region: 2027-2032
- 5.4 North America Aprotinin Market Facts & Figures by Country
- 5.4.1 North America Aprotinin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aprotinin Sales by Country (2021-2032)
- 5.4.3 North America Aprotinin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Aprotinin Market Facts & Figures by Country
- 5.5.1 Europe Aprotinin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aprotinin Sales by Country (2021-2032)
- 5.5.3 Europe Aprotinin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Aprotinin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aprotinin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aprotinin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aprotinin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aprotinin Market Facts & Figures by Country
- 5.7.1 South America Aprotinin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aprotinin Sales by Country (2021-2032)
- 5.7.3 South America Aprotinin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Aprotinin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aprotinin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aprotinin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aprotinin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Aprotinin Sales by Type (2021-2032)
- 6.1.1 Global Aprotinin Sales by Type (2021-2032) & (g)
- 6.1.2 Global Aprotinin Sales Market Share by Type (2021-2032)
- 6.2 Global Aprotinin Revenue by Type (2021-2032)
- 6.2.1 Global Aprotinin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aprotinin Revenue Market Share by Type (2021-2032)
- 6.3 Global Aprotinin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aprotinin Sales by Application (2021-2032)
- 7.1.1 Global Aprotinin Sales by Application (2021-2032) & (g)
- 7.1.2 Global Aprotinin Sales Market Share by Application (2021-2032)
- 7.2 Global Aprotinin Revenue by Application (2021-2032)
- 7.2.1 Global Aprotinin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aprotinin Revenue Market Share by Application (2021-2032)
- 7.3 Global Aprotinin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aprotinin Value Chain Analysis
- 8.1.1 Aprotinin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aprotinin Production Mode & Process
- 8.2 Aprotinin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aprotinin Distributors
- 8.2.3 Aprotinin Customers
9 Global Aprotinin Analyzing Market Dynamics
- 9.1 Aprotinin Industry Trends
- 9.2 Aprotinin Industry Drivers
- 9.3 Aprotinin Industry Opportunities and Challenges
- 9.4 Aprotinin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst